Correlation Between DexCom and Cutera
Can any of the company-specific risk be diversified away by investing in both DexCom and Cutera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Cutera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Cutera Inc, you can compare the effects of market volatilities on DexCom and Cutera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Cutera. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Cutera.
Diversification Opportunities for DexCom and Cutera
Pay attention - limited upside
The 3 months correlation between DexCom and Cutera is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Cutera Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cutera Inc and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Cutera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cutera Inc has no effect on the direction of DexCom i.e., DexCom and Cutera go up and down completely randomly.
Pair Corralation between DexCom and Cutera
Given the investment horizon of 90 days DexCom Inc is expected to generate 0.28 times more return on investment than Cutera. However, DexCom Inc is 3.58 times less risky than Cutera. It trades about 0.11 of its potential returns per unit of risk. Cutera Inc is currently generating about -0.05 per unit of risk. If you would invest 6,982 in DexCom Inc on September 4, 2024 and sell it today you would earn a total of 949.00 from holding DexCom Inc or generate 13.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DexCom Inc vs. Cutera Inc
Performance |
Timeline |
DexCom Inc |
Cutera Inc |
DexCom and Cutera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DexCom and Cutera
The main advantage of trading using opposite DexCom and Cutera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Cutera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cutera will offset losses from the drop in Cutera's long position.DexCom vs. Baxter International | DexCom vs. West Pharmaceutical Services | DexCom vs. ResMed Inc | DexCom vs. The Cooper Companies, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |